"The addition of this five-partner team extends the capabilities of our 200-plus lawyer IP team," Morgan Lewis’ global IP ...
Morgan Stanley raised the firm’s price target on Edwards Lifesciences (EW) to $75 from $70 and keeps an Equal Weight rating on the shares.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback